Afonne OJ - Search Results

1

Impact of effluents from a car battery manufacturing plant in Nigeria on water, soil, and food qualities.

Orisakwe OE, Asomugha R, Afonne OJ, Anisi CN, Obi E, Dioka CE. Orisakwe OE, et al. Among authors: afonne oj. Arch Environ Health. 2004 Jan;59(1):31-6. doi: 10.3200/AEOH.59.1.31-36. Arch Environ Health. 2004. PMID: 16053207

2

Some pharmacological properties of Synclisia scabrida II.

Orisakwe OE, Afonne OJ, Dioka CE, Ufearo CS, Okpogba AN, Ofoefule SI. Orisakwe OE, et al. Among authors: afonne oj. Indian J Med Res. 1996 May;103:282-4. Indian J Med Res. 1996. PMID: 8707366

3

Zinc protection of mercury-induced hepatic toxicity in mice.

Afonne OJ, Orisakwe OE, Ndubuka GI, Akumka DD, Ilondu N. Afonne OJ, et al. Biol Pharm Bull. 2000 Mar;23(3):305-8. doi: 10.1248/bpb.23.305. Biol Pharm Bull. 2000. PMID: 10726883

4

Pharmacokinetics of diethylcarbamazine: prediction by concentration in saliva.

Ilondu N, Orisakwe OE, Ofoefule S, Afonne OJ, Obi E, Chilaka KC, Orish C. Ilondu N, et al. Among authors: afonne oj. Biol Pharm Bull. 2000 Apr;23(4):443-5. doi: 10.1248/bpb.23.443. Biol Pharm Bull. 2000. PMID: 10784424

5

Acceleration of body clearance of diethylCarbamazine by oral activated charcoal.

Orisakwe OE, Ilondu NA, Afonne OJ, Ofoefule SI, Orish CN. Orisakwe OE, et al. Among authors: afonne oj. Pharmacol Res. 2000 Aug;42(2):167-70. doi: 10.1006/phrs.2000.0667. Pharmacol Res. 2000. PMID: 10887047 Clinical Trial.

6

Low-dose mercury induces testicular damage protected by zinc in mice.

Orisakwe OE, Afonne OJ, Nwobodo E, Asomugha L, Dioka CE. Orisakwe OE, et al. Among authors: afonne oj. Eur J Obstet Gynecol Reprod Biol. 2001 Mar;95(1):92-6. doi: 10.1016/s0301-2115(00)00374-2. Eur J Obstet Gynecol Reprod Biol. 2001. PMID: 11267727

7

Effect of activated charcoal on diethylcarbamazine absorption in humans.

Orisakwe OE, Ilondu ND, Afonne OJ, Ofoefule SI, Orish CN, Agbasi PU. Orisakwe OE, et al. Among authors: afonne oj. Am J Ther. 2001 Jan-Feb;8(1):7-9. doi: 10.1097/00045391-200101000-00003. Am J Ther. 2001. PMID: 11304652 Clinical Trial.

8

Rifampicin pharmacokinetics with and without ciprofloxacin.

Orisakwe OE, Agbasi PU, Afonne OJ, Ofoefule SI, Obi E, Orish CN. Orisakwe OE, et al. Among authors: afonne oj. Am J Ther. 2001 May-Jun;8(3):151-3. doi: 10.1097/00045391-200105000-00003. Am J Ther. 2001. PMID: 11344382

9

Adsorptive capacity of activated charcoal for rifampicin with and without sodium chloride and sodium citrate.

Orisakwe OE, Afonne OJ, Agbasi PU, Ilondu NA, Ofoefule SI, Obi E. Orisakwe OE, et al. Among authors: afonne oj. Biol Pharm Bull. 2001 Jun;24(6):724-6. doi: 10.1248/bpb.24.724. Biol Pharm Bull. 2001. PMID: 11411570 Free article.

10

Some plasma pharmacokinetic parameters of isoniazid in the presence of a fluoroquinolone antibacterial agent.

Ofoefule SI, Obodo CE, Orisakwe OE, Ilondu NA, Afonne OJ, Maduka SO, Anusiem CA, Agbasi PU. Ofoefule SI, et al. Among authors: afonne oj. Am J Ther. 2001 Jul-Aug;8(4):243-6. doi: 10.1097/00045391-200107000-00006. Am J Ther. 2001. PMID: 11441323 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page